Related Experiment Video
Updated: Feb 7, 2026

Direct Protein Delivery to Mammalian Cells Using Cell-permeable Cys2-His2 Zinc-finger Domains
Published on: March 25, 2015
KRAB-containing zinc finger protein ZNF496 inhibits breast cancer cell proliferation by selectively repressing ERα
Jinlong Wang1, Xiuyuan Zhang2, Jiming Ling3
1School of Bioscience and Technology, Weifang Medical University, Weifang, Shandong Province 261053, China; State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Beijing Institute of Lifeomics, Beijing 102206, China; Department of Pathology, The 422th Hospital of PLA, Zhanjiang, Guangdong Province 524000, China.
Abstract:
KRAB-containing zinc finger proteins (KZNF) constitute the largest family of transcriptional regulators in humans and play critical roles in normal development and tumorigenesis. However, the function and mechanism of most KZNFs remain unclear. Here, we report that ZNF496, a KZNF family member, interacts with the DNA binding domain (DBD) of estrogen receptor alpha (ERα) via its C2H2 domain. This interaction decreases ERα binding to chromatin DNA and results in the repression of ERα transactivation, the selective suppression of ERα target genes, and ultimately in a reduction of ERα-positive cell growth in the presence of E2. An analysis of clinical data revealed that the downregulation of ZNF496 expression is observed only in ERα-positive and not in ERα-negative breast cancer tissues when compared with that in matched adjacent tissues. Lastly, we also observed that the downregulation of ZNF496 is associated with poor recurrence-free survival among patients with breast cancer. Collectively, our findings demonstrate that ZNF496 is a novel ERα-binding protein that acts as a target gene-specific ERα corepressor and inhibits the growth of ERα-positive breast cancer cells.
Insights
ZNF496, a KRAB-containing zinc finger protein (KZNF), acts as a corepressor for estrogen receptor alpha (ERα). It inhibits ERα-positive breast cancer cell growth and its downregulation correlates with poor patient survival.
Area of Science:
- Molecular Biology
- Cancer Research
- Genetics
Background:
- KRAB-containing zinc finger proteins (KZFPs) are the largest family of human transcriptional regulators, crucial in development and cancer.
- The specific functions and mechanisms of most KZFPs are not well understood.
- Estrogen receptor alpha (ERα) is a key regulator in normal development and a driver of ERα-positive breast cancer.
Purpose of the Study:
- To investigate the function and mechanism of the KRAB-containing zinc finger protein ZNF496.
- To determine ZNF496's role in estrogen receptor alpha (ERα) activity and ERα-positive breast cancer.
Main Methods:
- Co-immunoprecipitation assays to identify protein interactions.
- Chromatin immunoprecipitation (ChIP) to assess DNA binding.
- Quantitative real-time PCR (qRT-PCR) to analyze gene expression.
- Analysis of clinical breast cancer patient data.
Main Results:
- ZNF496 directly interacts with the DNA binding domain of ERα via its C2H2 domain.
- This interaction reduces ERα binding to chromatin, represses ERα transactivation, and selectively suppresses ERα target genes.
- ZNF496 downregulation was observed in ERα-positive breast cancer tissues and associated with poorer recurrence-free survival.
Conclusions:
- ZNF496 is a novel ERα-binding protein and a target gene-specific ERα corepressor.
- ZNF496 inhibits the growth of ERα-positive breast cancer cells.
- Downregulation of ZNF496 is linked to adverse outcomes in breast cancer patients.
More Related Videos
Related Concept Videos
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Inhibition of Cdk Activity
Eukaryotic Transcription Activators
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These...
Feedback Inhibition
Repressed Memory
Cells Coordinate Growth and Proliferation

